Abstract
Conventional synthetic DMARD (csDMARD) therapy in patients with axial spondyloarthritis (SpA) is a matter of continuous debate. Part of this discussion is a dispute about methotrexate (MTX) comedication in patients...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have